Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,695 | 1,114 | 99.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96.14 | 3 | 0.5% |
| Education | $16.70 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,843 | 101 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,229 | 89 | $0 (2024) |
| UCB, Inc. | $959.16 | 41 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $851.45 | 52 | $0 (2024) |
| Biogen, Inc. | $798.52 | 46 | $0 (2024) |
| Amgen Inc. | $747.83 | 29 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $735.72 | 31 | $0 (2024) |
| Eisai Inc. | $728.64 | 33 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $718.67 | 34 | $0 (2024) |
| Allergan, Inc. | $695.84 | 43 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,549 | 158 | ABBVIE INC. ($616.20) |
| 2023 | $3,026 | 142 | AbbVie Inc. ($454.10) |
| 2022 | $2,473 | 144 | ABBVIE INC. ($275.94) |
| 2021 | $2,899 | 147 | AbbVie Inc. ($321.62) |
| 2020 | $1,854 | 112 | Amgen Inc. ($235.24) |
| 2019 | $2,894 | 169 | Novartis Pharmaceuticals Corporation ($323.73) |
| 2018 | $2,202 | 126 | Teva Pharmaceuticals USA, Inc. ($251.38) |
| 2017 | $1,911 | 121 | Sunovion Pharmaceuticals Inc. ($201.20) |
All Payment Transactions
1,119 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $38.78 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $34.17 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: PAIN | ||||||
| 11/12/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.04 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $34.60 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PAIN | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Adenosine A2A Receptors | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 713 | 980 | $355,957 | $92,153 |
| 2022 | 15 | 921 | 1,206 | $406,823 | $114,196 |
| 2021 | 13 | 1,001 | 1,375 | $415,825 | $133,712 |
| 2020 | 14 | 864 | 1,116 | $365,655 | $100,350 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 265 | $102,428 | $25,933 | 25.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 111 | 204 | $59,136 | $15,813 | 26.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 62 | 62 | $38,665 | $10,143 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $37,270 | $9,401 | 25.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 87 | 156 | $29,188 | $7,620 | 26.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 56 | 56 | $26,198 | $6,799 | 26.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 28 | 28 | $23,638 | $6,320 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 41 | $11,241 | $2,556 | 22.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $7,962 | $2,111 | 26.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 19 | 19 | $7,144 | $2,044 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $7,560 | $2,006 | 26.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 29 | 30 | $3,142 | $761.82 | 24.2% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 14 | 19 | $2,385 | $645.90 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 285 | $66,466 | $26,750 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $38,215 | $12,567 | 32.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 80 | 80 | $52,530 | $11,691 | 22.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 87 | 143 | $47,135 | $11,152 | 23.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 112 | 211 | $48,413 | $10,756 | 22.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 49 | 49 | $49,145 | $8,631 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 125 | $24,377 | $7,975 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 60 | $13,990 | $6,820 | 48.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $18,594 | $5,288 | 28.4% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 34 | 34 | $8,726 | $3,207 | 36.8% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 13 | 13 | $14,001 | $3,081 | 22.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 12 | 12 | $10,185 | $2,411 | 23.7% |
About Dr. Robert Waldrop, M.D
Dr. Robert Waldrop, M.D is a Neurology healthcare provider based in Johns Creek, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043372444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Waldrop, M.D has received a total of $20,808 in payments from pharmaceutical and medical device companies, with $3,549 received in 2024. These payments were reported across 1,119 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($20,695).
As a Medicare-enrolled provider, Waldrop has provided services to 3,499 Medicare beneficiaries, totaling 4,677 services with total Medicare billing of $440,411. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Johns Creek, GA
- Active Since 12/14/2006
- Last Updated 09/25/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043372444
Products in Payments
- Briviact (Drug) $852.61
- BOTOX (Biological) $736.43
- NUPLAZID (Drug) $718.67
- Aimovig (Biological) $704.61
- KESIMPTA (Drug) $623.14
- RYTARY (Drug) $583.98
- UBRELVY (Drug) $557.44
- TYSABRI (Biological) $483.12
- VYEPTI (Biological) $482.24
- GOCOVRI (Drug) $477.47
- AUBAGIO (Drug) $474.33
- INGREZZA (Drug) $470.08
- Fycompa (Drug) $461.11
- NURTEC ODT (Drug) $446.67
- DUOPA (Drug) $419.79
- QULIPTA (Drug) $416.55
- TROKENDI XR (Drug) $401.63
- Gamunex-C (Biological) $388.10
- AIMOVIG (Biological) $368.73
- Hizentra (Biological) $343.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.